Asked about his company's acquisition by Abbott Laboratories Inc. , Alza Corp. CEO Ernie Mario [See Deal]: "I was willing to fight P&U [Pharmacia & Upjohn Inc. , his company's nemesis in the incontinence wars]. I was. But given the battle—given that we had 300 reps and they had 1200—was it reasonable to ask our shareholders to continue to be patient?"
As if they'd ever been patient. For the five years of Mario's tenure, Alza shareholders have only grudgingly approved Alza's spending the kind of money it needed to build up...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?